References
- Schulz-Menger J, Collini V, Gröschel J, et al. 2025 ESC Guidelines for the management of myocarditis and pericarditis. Eur Heart J. 2025 Oct 22;46(40):3952-4041. doi: 10.1093/EURHEARTJ/EHAF192
- Imazio M. Prevenzione della sindrome postpericardiotomica, dei versamenti postoperatori e della fibrillazione atriale dopo interventi cardiochirurgici, efficacia e sicurezza della colchicina: evidenze dal trial COPPS e sottostudi. G Ital Cardiol (Rome). 2012 Oct;13(10):665-672. doi: 10.1714/1145.12619
- Imazio M, Brucato A, Ferrazzi P, et al. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. JAMA. 2014 Sep 10;312(10):1016-23. doi: 10.1001/jama.2014.11026
- Imazio M, Hoit BD Post-cardiac injury syndromes. An emerging cause of pericardial diseases. Int J Cardiol. 2013 Sep 30;168(2):648-52. doi: 10.1016/j.ijcard.2012.09.052
- Imazio M, Brucato A, Rovere ME, et al. Contemporary features, risk factors, and prognosis of the post-pericardiotomy syndrome. Am J Cardiol. 2011 Oct 15;108(8):1183-7. doi: 10.1016/j.amjcard.2011.06.025
- Andreis A, Imazio M, Giustetto C, Brucato A, Adler Y, De Ferrari GM. Anakinra for constrictive pericarditis associated with incessant or recurrent pericarditis. Heart. 2020 Oct;106(20):1561-1565. doi: 10.1136/heartjnl-2020-316898
- Lai R, Xu T. Update for diagnosis and treatment of syndrome after cardiac injury: a mini-review. Front Cardiovasc Med. 2025 Feb 5;12:1526671. doi: 10.3389/fcvm.2025.1526671. PMID: 39974595; PMCID: PMC11835860
- Malik J, Zaidi SMJ, Rana AS, Haider A, Tahir S. Post-cardiac injury syndrome: An evidence-based approach to diagnosis and treatment. Am Heart J Plus. 2021 Nov 19;12:100068. doi: 10.1016/j.ahjo.2021.100068
- van Osch D, Dieleman JM, Bunge JJ, et al. Risk factors and prognosis of postpericardiotomy syndrome in patients undergoing valve surgery. J Thorac Cardiovasc Surg. 2017 Apr;153(4):878-885.e1. doi: 10.1016/j.jtcvs.2016.10.075
- Imazio M, Negro A, Belli R, et al. Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention. Am J Cardiol. 2009 Jun 1;103(11):1525-9. doi: 10.1016/j.amjcard.2009.01.366
- Lehto J, Kiviniemi T, Gunn J, Airaksinen J, Rautava P, Kytö V. Occurrence of Postpericardiotomy Syndrome: Association With Operation Type and Postoperative Mortality After Open-Heart Operations. J Am Heart Assoc. 2018 Nov 20;7(22):
e010269 . doi: 10.1161/JAHA.118.010269 - Eren M, Velibey Y. Postcardiac Injury Syndrome Following Transcatheter Aortic Valve Implantation: A Brief Report and Review. Am J Cardiol. 2025 Apr 1;240:46-49. doi: 10.1016/j.amjcard.2024.12.036
- Llubani R, Böhm M, Imazio M, Fries P, Khreish F, Kindermann I. The first post-cardiac injury syndrome reported following transcatheter aortic valve implantation: a case report. Eur Heart J Case Rep. 2018 Sep 28;2(4):yty107. doi: 10.1093/ehjcr/yty107
- Alachkar MN, Lehrke M, Marx N, Almalla M. Post-cardiac injury syndrome after transcatheter mitral valve repair using MitraClip system: a case report. Eur Heart J Case Rep. 2020 Jul 21;4(4):1-5. doi: 10.1093/ehjcr/ytaa143
- Campbell NJ, Sneij E, Al-Adwan SA, Wiisanen M. Pericarditis after transcatheter aortic valve replacement, a rarely reported post-cardiac syndrome. J Am Coll Cardiol. 2021 May 3;77(18):2476. doi: 10.1016/S0735-1097(21)03831-6
- Hsu JC, Darden D, Du C, et al. Initial Findings From the National Cardiovascular Data Registry of Atrial Fibrillation Ablation Procedures. J Am Coll Cardiol. 2023 Mar 7;81(9):867-878. doi: 10.1016/j.jacc.2022.11.060
- Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015 Nov 7;36(42):2921-2964. doi: 10.1093/eurheartj/ehv318
- Imazio M, Trinchero R. Triage and management of acute pericarditis. Int J Cardiol. 2007 Jun 12;118(3):286-94. doi: 10.1016/j.ijcard.2006.07.100
- Toldo S, Mezzaroma E, Buckley LF, et al. Targeting the NLRP3 inflammasome in cardiovascular diseases. Pharmacol Ther. 2022 Aug;236:108053. doi: 10.1016/j.pharmthera.2021.108053
- Platek NM, Persits I, Khayata M, Badwan OZ, El Roumi J, Klein AL. Post-Cardiac Injury Syndrome: A Paradigm Shift in Diagnosis and Management. JACC Adv. 2025 Oct;4(10 Pt 2):102166. doi: 10.1016/j.jacadv.2025.102166
- Imazio M, Trinchero R, Brucato A, et al. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010 Nov;31(22):2749-54. doi: 10.1093/eurheartj/ehq319
- Imazio M, Brucato A, Markel G, et al. Meta-analysis of randomized trials focusing on prevention of the postpericardiotomy syndrome. Am J Cardiol. 2011 Aug 15;108(4):575-9. doi: 10.1016/j.amjcard.2011.03.087
- Mott AR, Fraser CD, Kusnoor AV, et al. The effect of short-term prophylactic methylprednisolone on the incidence and severity of postpericardiotomy syndrome in children undergoing cardiac surgery with cardiopulmonary bypass. J Am Coll Cardiol. 2001 May;37(6):1700-6. doi: 10.1016/s0735-1097(01)01223-2
- Bunge JJ, van Osch D, Dieleman JM, et al. Dexamethasone for Cardiac Surgery (DECS) Study Group. Dexamethasone for the prevention of postpericardiotomy syndrome: A DExamethasone for Cardiac Surgery substudy. Am Heart J. 2014 Jul;168(1):126-31.e1. doi: 10.1016/j.ahj.2014.03.017
- Gill PJ, Forbes K, Coe JY. The effect of short-term prophylactic acetylsalicylic acid on the incidence of postpericardiotomy syndrome after surgical closure of atrial septal defects. Pediatr Cardiol. 2009 Nov;30(8):1061-7. doi: 10.1007/s00246-009-9495-1
- Inan MB, Yazıcıoglu L, Eryılmaz S, et al. Effects of prophylactic indomethacin treatment on postoperative pericardial effusion after aortic surgery. J Thorac Cardiovasc Surg. 2011 Feb;141(2):578-82. doi: 10.1016/j.jtcvs.2010.03.021
- Schulz-Menger J, Collini V, Gröschel J, et al. 2025 ESC Guidelines for the management of myocarditis and pericarditis. Eur Heart J. 2025 Oct 22;46(40):3952-4041. doi: 10.1093/eurheartj/ehaf192
- Pryor K, Tarter L, Economy K, et al. Pericarditis Management in Individuals Contemplating Pregnancy, Currently Pregnant, or Breastfeeding. Curr Cardiol Rep. 2023 Oct;25(10):1103-1111. doi: 10.1007/s11886-023-01930-6
- Imazio M, Brucato A, Rampello S, et al. Management of pericardial diseases during pregnancy. J Cardiovasc Med (Hagerstown). 2010 Aug;11(8):557-62. doi: 10.2459/JCM.0b013e3283352356
- Ibrahim M, Fattouh M, Jacobs A. Management of Recurrent Pregnancy-Related Pericarditis. Case Rep Cardiol. 2022 Mar 22;2022:5791307. doi: 10.1155/2022/5791307
- Imazio M, Brucato A. Management of pericarditis in women. Womens Health (Lond). 2012 May;8(3):341-8. doi: 10.2217/whe.12.9
- Pryor K, Tarter L, Economy K, et al. Pericarditis Management in Individuals Contemplating Pregnancy, Currently Pregnant, or Breastfeeding. Curr Cardiol Rep. 2023 Oct;25(10):1103-1111. doi: 10.1007/s11886-023-01930-6
- El Hasbani G, Jawad A, Uthman I. Colchicine: An Ancient Drug with Multiple Benefits. Curr Pharm Des. 2021;27(26):2917-2924. doi: 10.2174/1381612826666201023144320
- Thomas GK, Bonaventura A, Vecchié A, et al. Interleukin-1 Blockers for the Treatment of Recurrent Pericarditis: Pathophysiology, Patient-Reported Outcomes, and Perspectives. J Cardiovasc Pharmacol. 2024 Jun 1;83(6):503-510. doi: 10.1097/FJC.0000000000001435
- Karmali R, Kafil TS, Bayat A, et al. Recurrent Pericarditis and Paradigm Shift in Cardiovascular Imaging and Targeted Therapeutics. JACC Adv. 2024 Sep 18;3(9):101194. doi: 10.1016/j.jacadv.2024.101194
- Götestam Skorpen C, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis. 2016 May;75(5):795-810. doi: 10.1136/annrheumdis-2015-208840
- Trotta L, Mascolo R, Mardygan V, et al. Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: A case series. Eur J Obstet Gynecol Reprod Biol. 2025 Aug;312:114553. doi: 10.1016/j.ejogrb.2025.114553
- Orabona R, Zanardini C, Zatti S, et al. Onset of idiopathic recurrent pericarditis during pregnancy: successful management with colchicine and intravenous immunoglobulins. J Cardiovasc Med (Hagerstown). 2020 May;21(5):393-395. doi: 10.2459/JCM.0000000000000904
- Schwier NC, Stephens K, Johnson PN. Management of Idiopathic Viral Pericarditis in the Pediatric Population. J Pediatr Pharmacol Ther. 2022;27(7):595-608. doi: 10.5863/1551-6776-27.7.595
- Imazio M, Venturelli F, Tomat MC, Savonitto G, Stolfo D, Collini V. Pericarditis at the crossroads: Unlocking the next wave of therapies. Int J Cardiol Heart Vasc. 2025 Nov 8;61:101841. doi: 10.1016/j.ijcha.2025.101841
- ClinicalTrials.gov [Internet]. Bethesda, MD: National Library of Medicine; c2026.
An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis ; 2026 February 17 [cited 2026 Feb 17]. Available from:https://clinicaltrials.gov/study/NCT06836232 - Cardiol Therapeutics [Internet]. Oakville, ON: Cardiol Therapeutics Inc; c2026.
Cardiol Therapeutics Enrolls First Patient in Phase III MAVERIC Trial in Recurrent Pericarditis ; 2025 April 16 [cited 2026 Feb 17]. Available from:https://www.cardiolrx.com/cardiol-therapeutics-enrolls-first-patient-in-pivotal-phase-iii-maveric-trial-in-recurrent-pericarditis/ - Brucato A, Imazio M, Gattorno M, et al. Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial. JAMA. 2016 Nov 8;316(18):1906-1912. doi: 10.1001/jama.2016.15826
- Klein AL, Imazio M, Cremer P, et al. Phase 3 Trial of Interleukin-1 Trap Rilonacept in Recurrent Pericarditis. N Engl J Med. 2021 Jan 7;384(1):31-41. doi: 10.1056/NEJMoa2027892
- Myachikova VY, Maslyanskiy AL, Moiseeva OM, et al. Treatment of Idiopathic Recurrent Pericarditis With Goflikicept: Phase II/III Study Results. J Am Coll Cardiol. 2023 Jul 4;82(1):30-40. doi: 10.1016/j.jacc.2023.04.046
- Kougkas N, Fanouriakis A, Papalopoulos I, et al. Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up. Rheumatology (Oxford). 2018 Aug 1;57(8):1494-1495. doi: 10.1093/rheumatology/key077
- Kiniksa [Internet]. La Jolla, CA: Kiniksa Pharmaceuticals; c2026.
Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis ; 2025 June 5 [cited 2026 Feb 17]. Available from:https://investors.kiniksa.com/news-releases/news-release-details/kiniksa-pharmaceuticals-announces-trial-design-planned-phase-23 - Collini V, Venturelli F, Quinzani F, Sappa R, Imazio M. Tolicizumab: a new option for refractory idiopathic recurrent pericarditis: a case report. Eur Heart J Case Rep. 2025 Oct 24;9(11):ytaf535. doi: 10.1093/ehjcr/ytaf535
- Lehto J, Kiviniemi T, Gunn J, Airaksinen J, Rautava P, Kytö V. Occurrence of Postpericardiotomy Syndrome: Association With Operation Type and Postoperative Mortality After Open-Heart Operations. J Am Heart Assoc. 2018 Nov 20;7(22):
e010269 . doi: 10.1161/JAHA.118.010269 - van Osch D, Nathoe HM, Jacob KA, et al. Determinants of the postpericardiotomy syndrome: a systematic review. Eur J Clin Invest. 2017 Jun;47(6):456-467. doi: 10.1111/eci.12764
- van Osch D, Dieleman JM, Bunge JJ, et al. Risk factors and prognosis of postpericardiotomy syndrome in patients undergoing valve surgery. J Thorac Cardiovasc Surg. 2017 Apr;153(4):878-885.e1. doi: 10.1016/j.jtcvs.2016.10.075
DOI: https://doi.org/10.14797/mdcvj.1783 | Journal eISSN: 1947-6108
Language: English
Page range: 27 - 40
Submitted on: Jan 11, 2026
Accepted on: Feb 13, 2026
Published on: Mar 10, 2026
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2026 Massimo Imazio, Mariacristina Tomat, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.